Back to Cancer Australia's website

Cancer Australia

Select a guideline

Recommendations for use of Bisphosphonates

in early breast cancer

NOVEMBER 2011 | Incorporates published evidence to June 2011

A CLINICAL PRACTICE GUIDELINE DEVELOPED BY CANCER AUSTRALIA*

This document supplements information contained in the Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.1

Recommendations for use of bisphosphonates for advanced breast cancer2 are also available from the Cancer Australia website.

ISBN Online: 978-1-74127-167-6

Cancer Australia 2011

Purpose

This guideline includes statements and recommendations based on available, high-level evidence about the use of bisphosphonates in early breast cancer. The guideline provides health professionals with information designed to help them make management recommendations for improved patient outcomes. Cancer Australia also develops information specifically for consumers about the diagnosis and treatment of early breast cancer.

Endorsed by:

* In July 2011, National Breast and Ovarian Cancer Centre (NBOCC) amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.

Published using CeCC Docbook Manager